Your session is about to expire
← Back to Search
Cognitive-Behavioural Therapy - Online (CBT-O) for Female Sexual Dysfunction
Study Summary
This trial will test whether online cognitive-behavioral therapy or mindfulness-based therapy can help women with sexual dysfunction, who may have negative physical, psychological, and interpersonal outcomes.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your sexual dysfunction is caused by another mental health condition, substance use, a medical condition, or relationship conflicts that are not the focus of this study.You cannot receive any other treatment for your sexual difficulties while participating in the study.You regularly take strong pain medications prescribed by a doctor or use illegal drugs (except cannabis).You are planning to change any medications that might affect your sexual function during the study.You are planning to break up with your romantic partner within the next 6 months.Women, regardless of sexual orientation, are eligible to participate.You have had sex with a partner in the last 4 weeks and are willing to have sex with your partner during the study. This is needed to measure sexual function.Women, including transgender women, of any sexual orientation.You have a condition that affects your ability to feel sexually interested or aroused, as determined through a phone screening.You need to meet specific criteria during a phone screening to be diagnosed with sexual interest/arousal disorder.The participant must be in a stable and committed romantic relationship for at least six months in order to participate in the interventionYou must have the ability to take part in an 8-12 week treatment program online.You have anxiety or mood disorders that significantly interfere with your daily life and have not been well managed.You have trouble seeing well enough to read things on the internet.The participant must have consistent access to the internet and be competent in using online platforms.
- Group 1: CBT-O
- Group 2: MBT-O
- Group 3: Wait-List Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the cap on enrolment for this clinical trial?
"Affirmative. The clinicaltrials.gov website confirms that, as of January 14th 2022, this medical trial is still recruiting participants - with 129 patients being sought at a single site since it's initial posting on November 12th 2021."
What is the purpose of this research endeavor?
"This clinical trial, which includes evaluation at baseline; mid-treatment (around 5 weeks after the commencement of an 8 module program); post-treatment (immediately after finishing the same 8 module course); and 6 months follow up seeks to assess Change in sexual desire. The secondary objectives include Treatment satisfaction for modules 1, 2 & 3. This is evaluated through a single item measure asking participants to rate helpfulness of content covered each week as well as ease of reading it on 0 to 10 scale where research suggests that score higher than 6.5/10 denotes acceptable utility and clarity regarding said content."
Are there any vacancies still available for participants in this trial?
"As per the latest information hosted on clinicaltrials.gov, this trial is actively recruiting suitable candidates for participation. The study was first announced on November 12th 2021 and its most recent update was posted on January 14th 2022."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger